The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.

N Prenzel, OM Fischer, S Streit, S Hart… - Endocrine-related …, 2001 - erc.bioscientifica.com
Homeostasis of multicellular organisms is critically dependent on the correct interpretation of
the plethora of signals which cells are exposed to during their lifespan. Various soluble …

Receptor tyrosine kinase signalling as a target for cancer intervention strategies.

E Zwick, J Bange, A Ullrich - Endocrine-related cancer, 2001 - erc.bioscientifica.com
In multicellular organisms, communication between individual cells is essential for the
regulation and coordination of complex cellular processes such as growth, differentiation …

A putative molecular-activation switch in the transmembrane domain of erbB2

SJ Fleishman, J Schlessinger… - Proceedings of the …, 2002 - National Acad Sciences
Overexpression of the receptor tyrosine kinase (RTK) erbB2 (also designated neu or HER2)
was implicated in causing a variety of human cancers, including mammary and ovarian …

The type 1 (EGFR-related) family of growth factor receptors and their ligands

SA Prigent, NR Lemoine - Progress in growth factor research, 1992 - Elsevier
This review considers the biology of the type 1 growth factor receptor family which is
increasingly recognised as important in the control of normal cell proliferation and in the …

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

D Xie, XO Shu, Z Deng, WQ Wen… - Journal of the …, 2000 - academic.oup.com
BACKGROUND: Alterations of the HER2 (also known as erbB-2 or neu) proto-oncogene
have been implicated in the carcinogenesis and prognosis of breast cancer. A …

Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

FFT Barros, DG Powe, IO Ellis, AR Green - Histopathology, 2010 - Wiley Online Library
Barros FFT, Powe DG, Ellis IO & Green AR (2010) Histopathology56, 560–572
Understanding the HER family in breast cancer: interaction with ligands, dimerization and …

Predicting drug response and toxicity based on gene polymorphisms

J Robert, V Le Morvan, D Smith, P Pourquier… - Critical reviews in …, 2005 - Elsevier
The sequencing of the human genome has allowed the identification of thousands of gene
polymorphisms, most often single nucleotide polymorphims (SNP), which may play an …

Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine …

WL Hsu, HM Huang, JW Liao, ML Wong… - The Veterinary Journal, 2009 - Elsevier
The aims of this study were to explore the relationship between clinical outcome and HER-2
protein expression in dogs with malignant mammary tumours after surgery and to determine …

Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab

J Lemieux, C Diorio, MA Cote, L Provencher… - Anticancer …, 2013 - ar.iiarjournals.org
Background: Trastuzumab has no major side-effects except the potential for cardiac toxicity.
The main objective of this study was to evaluate the association between trastuzumab …

[HTML][HTML] c-erbB-2 is not a major factor in the development of colorectal cancer

JA McKay, JF Loane, VG Ross, MM Ameyaw… - British journal of …, 2002 - nature.com
We have investigated c-erbB-2 protein expression in a large cohort of well-characterized
colorectal tumours, and in a subset of lymph node metastases. We have also evaluated a …